Literature DB >> 16608989

Maintenance chemotherapy in non-small cell lung cancer.

M Rinaldi1, O Belvedere, C Cauchi, C Defferrari, G Viola, F Grossi.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16608989     DOI： 10.1093/annonc/mdj928

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Exponential decay nonlinear regression analysis of patient survival curves: preliminary assessment in non-small cell lung cancer.

Authors:  David J Stewart; Carmen Behrens; Jack Roth; Ignacio I Wistuba
Journal:  Lung Cancer       Date:  2011-02       Impact factor: 5.705

2.  Approval summary: pemetrexed maintenance therapy of advanced/metastatic nonsquamous, non-small cell lung cancer (NSCLC).

Authors:  Martin H Cohen; Patricia Cortazar; Robert Justice; Richard Pazdur
Journal:  Oncologist       Date:  2010-12-10

3.  Treatment rationale and study design for a phase III, double-blind, placebo-controlled study of maintenance pemetrexed plus best supportive care versus best supportive care immediately following induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small cell lung cancer.

Authors:  Luis G Paz-Ares; Sedat Altug; Alexandra Thareau Vaury; Jesús Corral Jaime; Francesca Russo; Carla Visseren-Grul
Journal:  BMC Cancer       Date:  2010-03-08       Impact factor: 4.430

4.  Genistein enhances the effect of cisplatin on the inhibition of non-small cell lung cancer A549 cell growth in vitro and in vivo.

Authors:  Dezhi Liu; Ling Yan; Lan Wang; Weicheng Tai; Weili Wang; Changbin Yang
Journal:  Oncol Lett       Date:  2014-10-09       Impact factor: 2.967

Review 5.  [Advances of molecular targeted drugs used in maintenance therapy of non-small cell lung cancer].

Authors:  Tao Zhang; Li Shan; Dongming Zhang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2010-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.